Acute viral load blips in response to subcutaneous interleukin-2 therapy in HIV-1 infected individuals on highly active antiretroviral therapy

被引：0
|
作者：
Sullivan, AK
Imami, N
Hardy, GAD
Pires, A
O'Donavan, B
Gotch, FM
Gazzard, BG
机构：
[1] Chelsea & Westminster Hosp, Dept HIV GU Med, London, England
[2] ICSM, Dept Immunol, London, England
来源：
AIDS | 2000年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P199
引用
收藏
页码：S73 / S74
页数：2
相关论文
共 50 条
  • [1] Interleukin-2 therapy in HIV-1 infected individuals with late stage disease and failing antiretroviral therapy
    Sullivan, AK
    Nelson, MR
    Pozniak, AL
    Gazzard, BG
    AIDS, 2000, 14 : S74 - S74
  • [2] Changes in HIV-1, viral load trends with highly active antiretroviral therapy
    Chew, CB
    Leroi, MJ
    Workman, C
    Dwyer, CE
    MEDICAL JOURNAL OF AUSTRALIA, 2001, 174 (04) : 199 - 200
  • [3] Immune activation despite suppressive highly active antiretroviral therapy is associated with higher risk of viral blips in HIV-1-infected individuals
    Zoufaly, A.
    Kiepe, J. G.
    Hertling, S.
    Huefner, A.
    Degen, O.
    Feldt, T.
    Schmiedel, S.
    Kurowski, M.
    van Lunzen, J.
    HIV MEDICINE, 2014, 15 (08) : 449 - 457
  • [4] The distribution of viral blips observed in HIV-1 infected patients treated with combination antiretroviral therapy
    Jerome K. Percus
    Ora E. Percus
    Martin Markowitz
    David D. Ho
    Michele Di Mascio
    Alan S. Perelson
    Bulletin of Mathematical Biology, 2003, 65 : 263 - 277
  • [5] The distribution of viral blips observed in HIV-1 infected patients treated with combination antiretroviral therapy
    Percus, JK
    Percus, OE
    Markowitz, M
    Ho, DD
    Di Mascio, M
    Perelson, AS
    BULLETIN OF MATHEMATICAL BIOLOGY, 2003, 65 (02) : 263 - 277
  • [6] TILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individuals
    Angus, Brian
    Lampe, Fiona
    Tambussi, Guiseppe
    Duvivier, Claudine
    Katlama, Christine
    Youle, Mike
    Williams, Ian
    Clotet, Bonaventura
    Fisher, Martin
    Post, Frank A.
    Babiker, Abdul
    Phillips, Andrew
    AIDS, 2008, 22 (06) : 737 - 740
  • [7] Efficacy of highly active antiretroviral therapy in HIV-1 infected children
    van Rossum, AMC
    Fraaij, PLA
    de Groot, R
    LANCET INFECTIOUS DISEASES, 2002, 2 (02): : 93 - 102
  • [8] Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy
    Frater, AJ
    Dunn, DT
    Beardall, AJ
    Ariyoshi, K
    Clarke, JR
    McClure, MO
    Weber, JN
    AIDS, 2002, 16 (08) : 1139 - 1146
  • [9] Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial
    Levy, Y
    Durier, C
    Krzysiek, R
    Rabian, C
    Capitant, C
    Lascaux, AS
    Michon, C
    Oksenhendler, E
    Weiss, L
    Gastaut, JA
    Goujard, C
    Rouzioux, C
    Maral, J
    Delfraissy, JF
    Emilie, D
    Aboulker, JP
    AIDS, 2003, 17 (03) : 343 - 351
  • [10] Healthy HIV-1-Infected Individuals on Highly Active Antiretroviral Therapy Harbor HIV-1 in Their Alveolar Macrophages
    Cribbs, Sushma K.
    Lennox, Jeffrey
    Caliendo, Angela M.
    Brown, Lou Ann
    Guidot, David M.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2015, 31 (01) : 64 - 70
12345